GlassScriptPhysician profile
Jeremy P Moore
NPI 1265676274
$48,206.58
in general payments reported to CMS, 2019-2025
11 companies · $2,479 in 2025
The $2,479 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $1,997 · 2021: $13K · 2022: $154 · 2023: $8,132 · 2024: $9,993 · 2025: $2,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,350 · Consulting Fee: $6,700 · Food and Beverage: $2,679 · Travel and Lodging: $2,300 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,350.00 |
| Consulting Fee | $6,700.00 |
| Food and Beverage | $2,679.14 |
| Travel and Lodging | $2,300.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $25,012.40 | 2019-2021 | |
| Altathera Pharmaceuticals LLC | $11,751.48 | 2023-2025 | Sotalol Hydrochloride |
| Abbott Laboratories | $4,247.49 | 2019-2025 | Ensite Precision, Ensite, Aveir |
| Medical Device Business Services, INC. | $2,500.00 | 2023-2024 | Carto 3 |
| Medtronic, INC. | $1,613.21 | 2021-2025 | Evera Mri Xt Dr Surescan, Harmony, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $1,179.70 | 2020-2025 | Rhythmia Mapping System, Farapulse |
| Medtronic Vascular, INC. | $1,153.65 | 2020 | |
| Paragonix Technologies, INC. | $297.20 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $260.29 | 2019-2024 | Opsumit, Uptravi |
| Cardiva Medical, INC. | $164.64 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Janssen Pharmaceuticals, INC | $26.52 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.